At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Profile Description:
The Clinical Trial Business Capability Change Manager role will provide tactical support, oversight and leadership on change initiatives within the Clinical Trial Business Capabilities system/technology projects. The role is accountable for ensuring change for clinical trial systems is adequately managed in an operational state within the area of capabilities while maintaining effective alignment of systems/technologies with other business processes. The role is also accountable for effecting change in a controlled manner, in compliance with regulatory requirements while maintaining the clinical trial business capability in an inspection readiness state. The Business Capability Change Manager will work closely with the Business Capability Lead to plan Change Management activities specific to a Clinical Trial Business Capability, including training, testing, documentation and process mapping. This is an essential role to the success of the Clinical Trial Business Capabilities organization to support an effective change process leading into a stable operational state across several business capabilities.
Key Responsibilities and Major Duties
* Serves as Key Subject Matter Expert for change management activities within the clinical trial business capabilities and associated system/technology, including Stakeholder mapping, Stakeholder engagement, Training, Business Process Impact Analysis, and Adoption Strategy/Metrics.
* Support in the development, execution, and monitoring of the system/technology Change Management Plan in collaboration with key stakeholders.
* Lead Stakeholder Engagement meetings to ensure awareness is maintained across stakeholder groups around Business Capabilities
* Partners with R&D functions, internal and external on implementation, and oversight of new and existing platform capabilities.
* Responsible for the development of system and reporting requirements for the Clinical Trial Business Capability in partnership with IT colleagues
* Support activities for system/technology performance, project budget, stakeholder communications/change management.
* Lead training and communication for stakeholders impacted by change initiatives to the application or system processes for specific capabilities. Liaise with user forums or working groups
* Partners with the R&D Learning on development of training materials
* Delivers training to trainers and super-users (train-the-trainer)
* Supports user acceptance testing of system enhancements and upgrades, providing SME advice on testing approach, script writing, review and approval.
* Lead testing and support validation efforts for business capabilities, including participating in Operational Qualification and Performance Qualification of systems.
* Defining a suitable test strategy and writing test cases to support release management of systems/technologies within a specific clinical trial business capability.
* Participate in system/technology work streams and outcomes in change initiatives.
* Contributes to internal/external continuous improvement initiatives.
Requirements:
Bachelors degree required with an advanced degree preferred. Minimum of 3-5 years of direct experience independently leading and managing clinical trial (study, data, or system/technology) change management activities plus 1-2 years in a project management position directing system, process, program or quality activities. Significant, demonstrated breadth of experience, versatility, and independent leadership and stakeholder management skills. A minimum 3+ years experience working on system enhancements, incl. requirements, user acceptance testing, rollout of new functionality, documentation of system related business processes.
* Experience in clinical trial, data, or technology management
* Knowledge of Clinical Trial Business Capabilities such as eTMF, eConsent, EDC, Clinical Trial Portals, Patient Portals, HCP Portals, eCOA, Clinical Trial Data Capabilities and Clinical Trial Monitoring.
* Knowledge of GCP/ICH guidelines, regulations
* Experience with Change Management principles and best practices for technology systems
* Experience in computer system validation with GCP requirements
* Ability to analyze and interpret complex issues and propose innovative solutions
* Experience with driving innovation
* Strong project management and planning skills
* Effective oral and written communication skills to influence, inform, or guide others
* Ability to effectively respond to regulatory trends, internal audits, inspection activities including root cause analysis/Corrective Action/Preventive Action (CAPA) plans for any findings.
* Experience working in a matrix environment.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.